The psychedelics industry has huge potential shackled by uncertainty. The post What’s in store for psychedelics in 2024 appeared first on Green Market...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
–Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”)...
Cybin Inc. (NYSE: CYBN) announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for CYB004,...
2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before...
Highlights: Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid...
New Jersey lawmakers were able to legalize cannabis and now they have their sights set on psychedelics. Legislature sponsored by state senator Nicholas...
“Healing October 7th: Using MDMA for PTSD in Israel” is a live webinar event brought to you by Maps Israel, Neuly, and Psychedelic Invest. It will...
Toronto-based PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is expecting to get full approval from the U.S. Food and Drug Administration (FDA) ...